Omslagafbeelding van de show Labcat.ai Read Alzheimer's Disease Paper

Labcat.ai Read Alzheimer's Disease Paper

Podcast door meng

Engels

Gezondheid & Persoonlijke Ontwikkeling

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode.Elk moment opzegbaar.

  • 20 uur luisterboeken / maand
  • Podcasts die je alleen op Podimo hoort
  • Gratis podcasts
Probeer gratis

Over Labcat.ai Read Alzheimer's Disease Paper

• 🧠 The best Alzheimer's Disease Paper published yesterday, ranked by impact factor • 🏥 Clinical insights and how institutions are responding • 💡 Therapeutic innovations and emerging treatment targets • 🎯 Practical takeaways for physicians, neurologists, and medical researchers Get journal's impact factors at : https://www.journalmetrics.org Find clinical trials easily : https://www.clinicaltrialsfind.com Find NIH grants trend: https://www.gotgrant.com

Alle afleveringen

238 afleveringen

aflevering June 29, 2026 - Alzheimer Research Update artwork

June 29, 2026 - Alzheimer Research Update

June 29, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: Neuroprotective Effects of Tenoxicam and Phenethyl Isothiocyanate in an Aβ₁₋₄₂-Induced Rat Model of Alzheimer's Disease: Modulation of NF-κB/NLRP3 Signaling and Redox Homeostasis. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

Gisteren - 2 min
aflevering June 28, 2026 - Alzheimer Research Update artwork

June 28, 2026 - Alzheimer Research Update

June 28, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: RNA G-quadruplexes function as a tunable switch of FUS phase separation. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

28 jun 2026 - 2 min
aflevering June 27, 2026 - Alzheimer Research Update artwork

June 27, 2026 - Alzheimer Research Update

June 27, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: Extracellular vesicle-mediated bidirectional communication between the brain and peripheral organs in Alzheimer's disease: evidence, mechanisms, and translational perspectives. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

27 jun 2026 - 2 min
aflevering June 26, 2026 - Alzheimer Research Update artwork

June 26, 2026 - Alzheimer Research Update

June 26, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: From Plastics to Pathology: The Neurodegenerative Impact of Bisphenol-A on Alzheimer's Disease. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

26 jun 2026 - 1 min
aflevering June 25, 2026 - Alzheimer Research Update artwork

June 25, 2026 - Alzheimer Research Update

June 25, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: Comparative efficacy and safety of pathway-targeted pharmacotherapies for Alzheimer's disease: a systematic review and network meta-analysis of phase III trials. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

25 jun 2026 - 2 min
Super app. Onthoud waar je bent gebleven en wat je interesses zijn. Heel veel keuze!
Super app. Onthoud waar je bent gebleven en wat je interesses zijn. Heel veel keuze!
Makkelijk in gebruik!
App ziet er mooi uit, navigatie is even wennen maar overzichtelijk.

Kies je abonnement

Meest populair

Premium

20 uur aan luisterboeken

  • Podcasts die je alleen op Podimo hoort

  • Geen advertenties in Podimo shows

  • Elk moment opzegbaar

Probeer 14 dagen gratis
Daarna € 9,99 / maand

Probeer gratis

Premium Plus

Onbeperkt luisterboeken

  • Podcasts die je alleen op Podimo hoort

  • Geen advertenties in Podimo shows

  • Elk moment opzegbaar

Probeer 30 dagen gratis
Daarna € 13,99 / maand

Probeer gratis

Alleen bij Podimo

Populaire luisterboeken

Veelgestelde vragen

Meer vragen & antwoorden
Probeer gratis

Probeer 14 dagen gratis. € 9,99 / maand na proefperiode. Elk moment opzegbaar.